Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 20 Jun 2024 for Pacific Biosciences of California, INC.. Read the official filing
Filing timeline
BuySaleKathy Ordonez
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Kathy Ordonez: trading record in brief
Filings by Kathy Ordonez span 2 companies, the busiest being Pacific Biosciences of California, Inc. and Quidel Corp. We count 4 filings; the first trade dates from 12 May 2021 and the latest from 18 June 2024.
The open-market record consists of 1 sale worth €33k, with no purchase. The rest of the record consists of 1 share grant and 2 option exercises.
The newest entry dates from 20 June 2024: a share grant, in Pacific Biosciences of California, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Kathy Ordonez
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
22,821 shares0Common StockSEC:0001299130-24-000154:0
324,515 shares@ US$2.9092.9% of flowCommon StockSEC:0001299130-24-000079:0
3,280 shares@ US$11.500.0095% mcap50.0% of flowCommon StockSEC:0001299130-22-000022:0
1,040 shares0Common StockSEC:0001209191-21-032970:0
4 of 4 declarations
